- [1]Zhou Z, Wen L, Huang G, Cao C, Ren Z, Tan T, Xiang Y, Deng C.Altered Peripheral B-Lymphocyte Subsets in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults.Diabetes Care, 2016, 39 (3) : 434-440..
- [2]Zhou Z, Wang CY, Hagopian WA, Liao Y, Li X, Huang G, Zheng P, Xiang Y, Xie Z, Lin J, Luo S.HLA Genetic Discrepancy Between Latent Autoimmune Diabetes in Adults and Type 1 Diabetes: LADA China Study No. 6.J Clin Endocrinol Metab, 2016, 101 (4) : 1693-1700..
- [3]et al, Zhu D, Liu J, Li Y, Hou C, Yang Z, Zhao Y, Yang L, Lin J, Huang G, Xiang Y, Li X, Liu L.Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3).Diabetes Care, 2015, 38 (1) : 16-21..
- [4]Xu A, Lam KS, Zhou Z, Bornstein SR, Tu Y, Zhang J, Ye D, Zhong L, Xiao Y, Wang Y.Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with β-cell autoimmunity in patients with type 1 diabetes.Diabetes, 2014, 63 (12) : 4239-4248.
- [5]Wen L, Wong FS, Zhou Z, Szczepanik M, Zhang X, Majewska-Szczepanik M, Tan Q.IRAK-M deficiency promotes the development of T1DM in NOD mice.Diabetes, 2014, 63 (8) : 2761-2775..
- [6]Zhou Z, Wang X, Leslie RD, Li X, Long Z, Huang G, Liu L, Xiang Y, Yang L, Zhao Y.Dipeptidyl peptidase 4 inhibitor sitagliptin maintains β-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study.J Clin Endocrinol Metab, 2014, 99 (5) : 876-880..
- [7]Zhou Z, Wang CY, Lu Q, Huang G, Lin J, Li X, Yang L, Hou C, Zheng Y, Wang Z.DNA methylation impairs TLR9 induced Foxp3 expression by attenuating IRF-7 binding activity in fulminant type 1 diabetes.J Autoimmun, 2013, 41: 50-59..
- [8]et al, Leslie RD, Hagopian WA, Liu Z, Lin J, Yang L, Huang G, Ning G, Jia W, Ji L, Xiang Y, Zhou Z.Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study.Diabetes, 2013, 62 (2) : 543-530..
- [9]Lam KS, Zhou Z, Liu S, Yang L, Li X, Li H, Chen C, Law LS, Xu A, Xiao Y.Distinct changes in serum fibroblast growth factor 21 levels in different subtypes of diabetes.J Clin Endocrinol Metab, 2012, 91 (1) : 54-58..
- [10]Zhou Z, Leslie RD, Xu A, Liu Z, Huang G, Li X, Zhou P, Xiang Y.Heterogeneity of altered cytokine levels across the clinical spectrum of diabetes in China.Diabetes Care, 2011, 34 (7) : 1639-1641..
|